Bayer Cropscience signs agreement with GVK Biosciences on early-stage research projects

Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.

Press Release (PressBurner) Dec 03, 2009 - Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products. Under the agreement, Bayer CropScience will integrate GVK BIO capacities in the early part of its Discovery chemistry process.

“We want to further speed up the development of our successful crop protection R&D pipeline and we look forward to working with GVK BIO, Asia’s leading contract research organization”, said Dr. Alexander Klausener, Head of Research at Bayer Crop Science AG, at the signing ceremony in Hyderabad. “This cooperation in the area of early discovery chemistry will help Bayer Crop Science to further increase efficiency in its Research. It will also help our company to participate in the quickly developing scientific environment in India.”

”GVK Biosciences has built world-class capabilities in early Discovery Chemistry. We are excited to partner with Bayer Crop Sciences to strengthen and accelerate their hits”, said Manni Kantipudi, President, GVK Biosciences. “Agri & Crop Sciences Research is a key focus area for GVK BIO. We are happy with the trust imposed by Bayer and look forward to working with one of the most innovative agri companies.”

With expenditures of EUR 649 million in research and development in 2008, Bayer CropScience is one of the leading innovative companies in the agricultural industry. In 2008, the insecticides spirotetramat and the herbicide pyrasulfotole have been launched successfully. Three fungicides fluopyr am, bixafen and isotianil are scheduled for launch in 2010 and 2011. Three further candidates are at an advanced stage of development.

# # #

Release Date: 
Thursday, December 3, 2009 - 5:30am
Additional Tags: 
gvk bio, bayer, contract research organisation
Media Contact
First Name: 
GVK Biosciences
Last Name: 
Private Limited
Email: 
Contact
Country: 
India
State: 
Andra Pradesh